EUVIMEDEUVIMED entdecken
LeserbriefKohortenstudie

Malignancy Risk Among Psoriasis Patients Treated With Interleukin Inhibitors: A Retrospective Matched-Cohort Study

Zaryab Alam, Kevin T Nguyen, Kritin K Verma, Anuj Kunadia, Jarad I Levin

Cutis · 01.03.2026 · 3 (117)

DOI: 10.12788/cutis.1352 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cutis, erschienen am 01.03.2026. Verfasst von Zaryab Alam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zaryab Alam is from the College of Medicine, Texas A&M University, Bryan. Kevin T. Nguyen and Kritin K. Verma are from the School of Medicine, Texas ….

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Zaryab Alam is from the College of Medicine, Texas A&M University, Bryan. Kevin T. Nguyen and Kritin K. Verma are from the School of Medicine, Texas Tech University Health Sciences Center, Lubbock. Drs. Kunadia and Levi…

Zitieren

APA

Alam, Z., Nguyen, K. T., Verma, K. K., Kunadia, A., & Levin, J. I. (2026). Malignancy Risk Among Psoriasis Patients Treated With Interleukin Inhibitors: A Retrospective Matched-Cohort Study. Cutis, 3(117). https://doi.org/10.12788/cutis.1352

Vancouver

Alam Z, Nguyen KT, Verma KK, Kunadia A, Levin JI. Malignancy Risk Among Psoriasis Patients Treated With Interleukin Inhibitors: A Retrospective Matched-Cohort Study. Cutis. 2026;3(117). doi:10.12788/cutis.1352

BibTeX
@article{Alam2026,
  author = {Alam, Zaryab and Nguyen, Kevin T and Verma, Kritin K and Kunadia, Anuj and Levin, Jarad I},
  title = {Malignancy Risk Among Psoriasis Patients Treated With Interleukin Inhibitors: A Retrospective Matched-Cohort Study},
  journal = {Cutis},
  year = {2026},
  volume = {3},
  number = {117},
  doi = {10.12788/cutis.1352}
}
Kostenlos starten →